Antiviral Drugs Market Share, Growth Factor, Industry Size and Forecast 2026

The Global “Antiviral Drugs Market” is set to gain impetus from the improvements in research collaborations of industry giants to develop state-of-the-art therapeutics. Besides, the increasing prevalence of viral diseases would impact the market positively. Fortune Business Insights™ published this information in a recent study, titled, “Antiviral Drugs Market Size, Share & Industry Analysis, By Drug Class (Protease Inhibitors, Polymerase Inhibitors, Integrase Inhibitors, Combination Drugs, Reverse Transcriptase Inhibitors, and Others), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel) and Regional Forecast, 2019-2026.” The study further mentions that the antiviral drugs market size is projected to reach USD 44.2 billion by 2026, thereby exhibiting a CAGR of 3.2% during the forecast period. However, it stood at USD 36.1 billion in 2018.

Get Detailed Analysis on Antiviral Drugs Market Research Report

Key Players Operating in The Antiviral Drugs Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Abbvie, Inc.
Novartis AG
Gilead Sciences
Mylan N.V.
GlaxoSmithKline
Merck & Co., Inc.
Janssen Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
High Demand for Targeted & Specific Treatment Regimen to Boost Growth

One of the most common forms of viral infection that is occurring across the world is HIV. The diagnosis rate of HIV is improving gradually owing to the refinement of surveillance by using biological and demographic data. The World Health Organization (WHO) stated that in the year 2018, approximately 37.9 million people were affected by HIV. However, around 770,000 people died of this disease. It proves that the rising cases of HIV is fueling the demand for specific and targeted treatment regimen. Apart from that, the rising prevalence of influenza and its efficient diagnosis are set to drive the antiviral drugs market growth in the coming years.

Request A Sample Copy Antiviral Drugs Market Report

Increasing Outburst of Viral Diseases to Favor Growth in Asia Pacific

Geographically, the market is divided into the Middle East and Africa, North America, Europe, Asia Pacific, and Latin America. Out of these, North America held USD 13.9 billion antiviral drugs market revenue in 2018. This growth is attributable to the presence of various key pharmaceutical companies in the U.S. Coupled with this, green signal by USFDA for the launch of effective and blockbuster therapies, as well as rising incidence of HIV in this country are set to augment growth in North America. Europe is also expected to grow remarkably on account of the presence of favorable reimbursement policies.

Detailed Table of Content:

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Key Industry Trends
Recent industry developments such as mergers & acquisitions
regulatory and reimbursement scenario for key countries
Prevalence of Key viral diseases, in major countries, 2018
New Product Launches
Global Antiviral Drugs Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Disease Indication
Hepatitis
Human Immunodeficiency Virus (HIV)
Influenza
Others
Market Analysis, Insights and Forecast – By Drug Class
Integrase Inhibitors
Polymerase Inhibitors
Protease Inhibitors
Combination Drugs
Reverse Transcriptase Inhibitors
Others
Market Analysis, Insights and Forecast – By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Channel
Market Analysis, Insights and Forecast – By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Have Any Query? Ask Our Research Experts

Report Focus:

Extensive product offerings
Customer research services
Robust research methodology
Comprehensive reports
Latest technological developments
Value chain analysis
Potential Antiviral Drugs Market opportunities
Growth dynamics
Quality assurance
Post-sales support
Regular report updates
KEY QUESTIONS ANSWERED:

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the Antiviral Drugs Market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs